Target intelligence / Profile preview

Nicotinic Acetylcholine Receptor (Neuromuscular Junction) (nAChR)

Target
nAChR
Molecular classification
Ligand-gated ion channel, Receptor
01

Overview

The nicotinic acetylcholine receptor (nAChR) at the neuromuscular junction is a pentameric ligand-gated cation channel essential for converting neural signals into muscular action. Its unique structure enables rapid response upon neurotransmitter binding—making it vital for all voluntary movements—and it serves as an important pharmacological target both clinically and evolutionarily. It is composed of five subunits (2α1, β1, δ, and γ/ε) and is activated by acetylcholine, leading to sodium and potassium ion flux and subsequent muscle contraction. Dysfunction of this receptor is implicated in diseases like myasthenia gravis.

Other names
Muscle-type Nicotinic Acetylcholine ReceptorNeuromuscular Junction nAChRnAChR at the Neuromuscular Junction
02

Mechanism of action

Agonist binding leads to channel opening and ion influx/efflux, causing membrane depolarization. Antagonists block the receptor, preventing acetylcholine binding and subsequent depolarization.

03

Biological functions

Synaptic transmissionMuscle contractionIon transportSignal transduction
04

Disease associations

Myasthenia GravisLambert-Eaton Myasthenic Syndrome (indirectly)
05

Safety considerations

Neuromuscular blockade (excessive paralysis)Respiratory depressionCardiac effects (depending on the specific drug and dose)
06

Interacting drugs

Acetylcholine

6 more in the full profile.

07

Biomarkers

Anti-AChR antibodies (Myasthenia Gravis)

Beyond the preview

Go deeper on Nicotinic Acetylcholine Receptor (Neuromuscular Junction) (nAChR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nicotinic Acetylcholine Receptor (Neuromuscular Junction) (nAChR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call